AbbVie Inc. (ABBV)
NYSE: ABBV · IEX Real-Time Price · USD
-3.76 (-2.15%)
Jul 18, 2024, 3:27 PM EDT - Market open

AbbVie Statistics

Total Valuation

AbbVie has a market cap or net worth of $302.48 billion. The enterprise value is $359.83 billion.

Market Cap 302.48B
Enterprise Value 359.83B

Important Dates

The next confirmed earnings date is Thursday, July 25, 2024, before market open.

Earnings Date Jul 25, 2024
Ex-Dividend Date Jul 15, 2024

Share Statistics

AbbVie has 1.77 billion shares outstanding. The number of shares has decreased by -0.17% in one year.

Shares Outstanding 1.77B
Shares Change (YoY) -0.17%
Shares Change (QoQ) -0.17%
Owned by Insiders (%) 0.10%
Owned by Institutions (%) 72.66%
Float 1.76B

Valuation Ratios

The trailing PE ratio is 51.09 and the forward PE ratio is 14.67. AbbVie's PEG ratio is 0.45.

PE Ratio 51.09
Forward PE 14.67
PS Ratio 5.59
Forward PS 5.32
PB Ratio 37.95
P/FCF Ratio 13.88
PEG Ratio 0.45
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.16, with an EV/FCF ratio of 16.44.

EV / Earnings 60.04
EV / Sales 6.61
EV / EBITDA 20.16
EV / EBIT 39.10
EV / FCF 16.44

Financial Position

The company has a current ratio of 0.94, with a Debt / Equity ratio of 9.24.

Current Ratio 0.94
Quick Ratio 0.72
Debt / Equity 9.24
Debt / EBITDA 4.15
Debt / FCF 3.38
Interest Coverage 5.47

Financial Efficiency

Return on equity (ROE) is 55.30% and return on invested capital (ROIC) is 12.43%.

Return on Equity (ROE) 55.30%
Return on Assets (ROA) 4.30%
Return on Capital (ROIC) 12.43%
Revenue Per Employee $1.09M
Profits Per Employee $119,860
Employee Count 50,000
Asset Turnover 0.39
Inventory Turnover 5.08


In the past 12 months, AbbVie has paid $1.53 billion in taxes.

Income Tax 1.53B
Effective Tax Rate 20.30%

Stock Price Statistics

The stock price has increased by +25.61% in the last 52 weeks. The beta is 0.62, so AbbVie's price volatility has been lower than the market average.

Beta (5Y) 0.62
52-Week Price Change +25.61%
50-Day Moving Average 165.80
200-Day Moving Average 161.64
Relative Strength Index (RSI) 55.30
Average Volume (20 Days) 6,141,503

Short Selling Information

The latest short interest is 16.22 million, so 0.92% of the outstanding shares have been sold short.

Short Interest 16.22M
Short Previous Month 16.49M
Short % of Shares Out 0.92%
Short % of Float 0.92%
Short Ratio (days to cover) 2.53

Income Statement

In the last 12 months, AbbVie had revenue of $54.40 billion and earned $5.99 billion in profits. Earnings per share was $3.37.

Revenue 54.40B
Gross Profit 33.88B
Operating Income 12.79B
Pretax Income 7.52B
Net Income 5.99B
EBIT 9.20B
Earnings Per Share (EPS) $3.37
Full Income Statement

Balance Sheet

The company has $18.07 billion in cash and $74.00 billion in debt, giving a net cash position of -$55.93 billion or -$31.67 per share.

Cash & Cash Equivalents 18.07B
Total Debt 74.00B
Net Cash -55.93B
Net Cash Per Share -$31.67
Equity (Book Value) 8.01B
Book Value Per Share 4.53
Working Capital -2.65B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $22.69 billion and capital expenditures -$795.00 million, giving a free cash flow of $21.89 billion.

Operating Cash Flow 22.69B
Capital Expenditures -795.00M
Free Cash Flow 21.89B
FCF Per Share $12.38
Full Cash Flow Statement


Gross margin is 62.28%, with operating and profit margins of 23.50% and 11.02%.

Gross Margin 62.28%
Operating Margin 23.50%
Pretax Margin 13.82%
Profit Margin 11.02%
EBITDA Margin 32.81%
EBIT Margin 16.91%
FCF Margin 40.24%

Dividends & Yields

This stock pays an annual dividend of $6.20, which amounts to a dividend yield of 3.60%.

Dividend Per Share $6.20
Dividend Yield 3.60%
Dividend Growth (YoY) 4.79%
Years of Dividend Growth 52
Payout Ratio 183.98%
Buyback Yield 0.17%
Shareholder Yield 3.73%
Earnings Yield 1.97%
FCF Yield 7.20%
Dividend Details

Analyst Forecast

The average price target for AbbVie is $185.00, which is 7.87% higher than the current price. The consensus rating is "Strong Buy".

Price Target $185.00
Price Target Difference 7.87%
Analyst Consensus Strong Buy
Analyst Count 12
Revenue Growth Forecast (5Y) 5.75%
EPS Growth Forecast (5Y) 43.08%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a


AbbVie has an Altman Z-Score of 1.82 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.82
Piotroski F-Score 5